Skip Navigation

2011 NIAID Year In Review

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Funding for Selected Pathogens, Diseases, and Conditions

NIAID reports how appropriated funds are spent in different categories and classifications, including by pathogen (disease-causing organism), specific disease or condition, and research area. The table below provides funding levels for areas of interest to NIAID stakeholders. These areas do not represent the entire NIAID research portfolio. Funding for these areas can overlap and does not add up to the total NIAID budget. For example, funding for West Nile virus is represented in several areas, including vector-borne diseases, tropical medicine, and infectious diseases.

How NIAID Reports Expenditures

  • NIH Research, Condition, and Disease Categories (RCDC)—In response to the NIH Reform Act of 2006 (Public Law No. 109-482), the National Institutes of Health (NIH) developed a consistent and transparent system to describe how NIH categorizes its research. RCDC reflects NIH funding levels in 229 research, condition, and disease categories.
  • Funding for NIAID research areas not reported through the RCDC process is coded and reported using the process in place before RCDC was implemented in FY 2008.

 

NIAID Funding for Selected Pathogens, Diseases, and Conditions – FY 2011

Pathogen, Disease, or Condition Dollars (in Thousands) Pathogen, Disease, or Condition Dollars (in Thousands)
Allergy
 $      51,243
Leishmaniasis
 $      18,662
Allergic Rhinitis1
5,741
Lupus1
47,112
Food Allergy1
28,385
Lyme Disease1
18,238
Anaphylaxis
5,145
Malaria1
114,461
Anthrax1
72,935
Multiple Sclerosis1
30,991
Arthritis1
34,553
Parasitic Diseases
258,236
Asthma1
56,594
Pandemic Influenza
243,112
Autoimmune Disease1
190,085
Pediatric (Research)1
260,324
Cholera
19,595
Pediatric AIDS
67,106
Dengue Virus
42,511
Pneumonia and Influenza1
300,166
Diabetes1
33,687
Primary Immune Deficiency Diseases
30,392
Diarrheal Diseases
177,588
Respiratory Diseases, Infectious
345,558
Digestive Diseases1
316,515
Sexually Transmitted Diseases / Herpes1
120,104
Ebola
42,879
Smallpox1
63,232
Emerging Infectious Diseases1
1,740,645
Staphylococcus aureus
87,849
Fungal Diseases
57,381
Methicillin-Resistant S. aureus 
58,715
Hepatitis1
79,927
Transmissible Spongiform Encephalopathies / Prions
12,264
Hepatitis C1
51,283
Tropical Medicine2
507,114
HIV/AIDS
1,563,349
Tuberculosis1
157,950
Infectious Diseases, including HIV/AIDS1
2,575,418
Vector-Borne Diseases1
393,499
Inflammatory Bowel Disease1
22,532
West Nile Virus1
62,032
Other Research Dollars (in Thousands) Other Research Dollars (in Thousands)
Antimicrobial Resistance1
275,170
Immune Tolerance
167,129
Biodefense
1,665,098
Prevention1
1,457,605
Antibiotics/Antivirals
339,840
Rare Diseases1
762,464
Basic Research
897,925
Stem Cell Research1
40,124
Chemical Countermeasures Research
47,890
Topical Microbicides1
76,190
Diagnostic
252,368
Translational Research
1,782,775
Radiological/Nuclear Research3
47,408
Transplantation1
124,600
Vaccines
337,414
Vaccine Development
1,277,812
Comparative Effectiveness Research1
67,614
HPV and/or Cervical Cancer Vaccines1
7,017
Food Safety1
219,022
Vaccine-Related (AIDS)
467,799

1Represents topics and funding levels reported using the NIH RCDC process
2Includes neglected tropical diseases
3NIAID coordinates/manages these programs on behalf of NIH.

Last Updated June 11, 2012

Last Reviewed June 11, 2012